Lannett New York Listing Under Threat As FDA Says No On Advair

Flurry Of Announcements Also Sees Lannett Agree Sale Of Carmel Site

 
• By Dean Rudge
  
Clock disintegrates, time running out concept
Lannett has 45 days to submit a business plan to the NYSE • Source: Piotr Adamowicz / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Business

More from Generics Bulletin